← back to search

Jesús Lascorz

Heidelberg University · DE
Area of research
Immunology · Epidemiology
Research interest
Research interests include Immune Response and Inflammation, Mycobacterium research and diagnosis, Cancer-related molecular mechanisms research, and Psoriasis: Treatment and Pathogenesis.
h-index
24
citations
3,824
works
60
NIH funding
primary concept
email

Recent publications

Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients’ Clinical Outcome
PLoS ONE 2014cited by 21position: middledoi
A Coding IRAK2 Protein Variant Compromises Toll-like receptor (TLR) Signaling and Is Associated with Colorectal Cancer Survival
Journal of Biological Chemistry 2014cited by 21position: middledoi
Association of PER2 Genotype and Stressful Life Events with Alcohol Drinking in Young Adults
PLoS ONE 2013cited by 68position: middledoi
Functional TLR5 Genetic Variants Affect Human Colorectal Cancer Survival
Cancer Research 2013cited by 67position: middledoi
Genetic variants in C‐type lectin genes are associated with colorectal cancer susceptibility and clinical outcome
International Journal of Cancer 2013cited by 29position: middledoi
Genetic Polymorphisms in Host Innate Immune Sensor Genes and the Risk of Nasopharyngeal Carcinoma in North Africa
G3 Genes Genomes Genetics 2013cited by 25position: middledoi
Genome-wide investigation of gene–environment interactions in colorectal cancer
Human Genetics 2012cited by 43position: middledoi
Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer
International Journal of Colorectal Disease 2012cited by 26position: firstdoi
Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer
BMC Medical Genetics 2012cited by 24position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Asta Försti · German Cancer Research Center8 papers (2012–2014)Kari Hemminki · Lund University7 papers (2012–2014)Melanie Bevier · Heidelberg University6 papers (2012–2014)Witigo von Schönfels · University Hospital Schleswig-Holstein4 papers (2012–2013)Jochen Hampe · Martin Luther University Halle-Wittenberg4 papers (2012–2013)Clemens Schafmayer · University of Rostock4 papers (2012–2014)Stefanie Huhn · Heidelberg University3 papers (2013–2014) · 2 papers (2012–2012)Thomas Becker · University Hospital Schleswig-Holstein2 papers (2012–2012)Stephan Buch · Heinrich Heine University Düsseldorf2 papers (2012–2012)Jan Beckmann · Novartis (Switzerland)2 papers (2012–2012)Alexander N.R. Weber · German Cancer Research Center2 papers (2013–2014) · 2 papers (2012–2012)Stefan Schreiber · Nutrition-Génétique et Exposition aux Risques Environnementaux2 papers (2012–2012)Bowang Chen · Central South University of Forestry and Technology2 papers (2012–2014) · 2 papers (2012–2012)Shun Lu · Fudan University Shanghai Cancer Center2 papers (2013–2013)Jórunn E. Eyfjörd · University of Iceland1 papers (2014–2014) · 1 papers (2012–2012) · 1 papers (2013–2013)